Your browser doesn't support javascript.
loading
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.
Tani, Hideki; Kimura, Miyuki; Tan, Long; Yoshida, Yoshihiro; Ozawa, Tatsuhiko; Kishi, Hiroyuki; Fukushi, Shuetsu; Saijo, Masayuki; Sano, Kaori; Suzuki, Tadaki; Kawasuji, Hitoshi; Ueno, Akitoshi; Miyajima, Yuki; Fukui, Yasutaka; Sakamaki, Ippei; Yamamoto, Yoshihiro; Morinaga, Yoshitomo.
Afiliação
  • Tani H; Department of Microbiology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan. toyamaeiken3@juno.ocn.ne.jp.
  • Kimura M; Department of Virology, Toyama Institute of Health, Toyama, Japan. toyamaeiken3@juno.ocn.ne.jp.
  • Tan L; Department of Microbiology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
  • Yoshida Y; Department of Microbiology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
  • Ozawa T; Department of Microbiology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
  • Kishi H; Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
  • Fukushi S; Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
  • Saijo M; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
  • Sano K; Department of Virology I, National Institute of Infectious Diseases, Tokyo, Japan.
  • Suzuki T; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
  • Kawasuji H; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
  • Ueno A; Department of Clinical Infectious Diseases, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
  • Miyajima Y; Department of Clinical Infectious Diseases, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
  • Fukui Y; Department of Clinical Infectious Diseases, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
  • Sakamaki I; Department of Clinical Infectious Diseases, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
  • Yamamoto Y; Department of Clinical Infectious Diseases, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
  • Morinaga Y; Department of Clinical Infectious Diseases, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
Virol J ; 18(1): 16, 2021 01 12.
Article em En | MEDLINE | ID: mdl-33435994
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes de Neutralização / Vírus da Estomatite Vesicular Indiana / Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / Teste Sorológico para COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudo: Evaluation_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes de Neutralização / Vírus da Estomatite Vesicular Indiana / Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / Teste Sorológico para COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudo: Evaluation_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article